This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Acknowledgements
The views expressed in this article are personal to the author and do not necessarily reflect those of other members of Foley & Lardner LLP or its clients.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Related links
FURTHER INFORMATION
PowerPoint slides
Rights and permissions
About this article
Cite this article
Brinckerhoff, C. Supreme Court decision favours biosimilars. Nat Rev Drug Discov 16, 521–522 (2017). https://doi.org/10.1038/nrd.2017.136
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2017.136